Burden of disease and costs of treating rotavirus diarrhea in mexican children for the period 2001-2006

Vaccine

Volumn 29, Issue 38, 2011, Pages 6712-6719

  Granados García, Víctor ^a   Velázquez, F Raúl ^b   Salmerón, Jorge ^c   Homedes, Nuria ^d   Salinas Escudero, Guillermo ^e   Morales Cisneros, Gabriela ^f  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^b HOSPITAL DE PEDIATRÍA   (Mexico)

^c INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

^d UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^e HOSPITAL INFANTIL DE MÉXICO FEDERICO GÓMEZ   (Mexico)

^f Centro de Estudios de Las Finanzas Públicas   (Mexico)

Author keywords

Burden of disease; Costs; Diarrhea; Mexico; Rotavirus

Indexed keywords

ROTAVIRUS VACCINE;

ARTICLE; CHILD; COST OF ILLNESS; DIARRHEA; HEALTH CARE ACCESS; HEALTH CARE COST; HUMAN; INCIDENCE; INFANT; MEXICO; NEWBORN; PARAMETER; PRESCHOOL CHILD; PRIORITY JOURNAL; QUALITY OF LIFE; ROTAVIRUS INFECTION;

CHILD, PRESCHOOL; DIARRHEA; HEALTH CARE COSTS; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MEXICO; ROTAVIRUS INFECTIONS;

EID: 80051669285     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.03.020     Document Type: Article

References (41)

1. Glass R.I., Parashar U.D., Bresee J.S., Turcios R., Fischer T.K., Widdowson M., et al. Rotavirus vaccines: current prospects and future challenges. Lancet 2006, 323-332.
2. Kane E.M., Turcios R.M., Arvay M.L., Garcia S., Bresee J.S., Glass R.I. The epidemiology of rotavirus diarrhea in Latin America. Anticipating rotavirus vaccines. Pan Am J Public Health 2004, 16(6):371-377.
3. Parashar U.D., Hummerlman E.G., Bresee J.S., Miller M.A., Glass R.I. Global illness and deaths caused by rotavirus disease in children. Emerg Infect Dis 2003, 9:565-572.
4. Parashar U.D., Gibson C.J., Bresse J.S., Glass R.I. Rotavirus and severe childhood diarrhea. Emerg Infect Dis 2006, 12(2):304-306.
5. Rheingans R., Constenla D., Antil L., Innis B.L., Breuer T. Potential cost-effectiveness of vaccination for rotavirus gastroenteritis in eight Latin American and Caribbean countries. Pan Am J Public Health 2007, 21(4):205-216.
6. Rheingans R., Constenla D., Antil L., Innis B.L., Breuer T. Economic and health burden of rotavirus gastroenteritis for the 2003 birth cohort in eight Latin American and Caribbean countries. Pan Am J Public Health 2007, 21(4):192-204.
7. Constenla D., Velazquez F.R., Rheingans R., Antil L., Cervantes Y. Economic impact of rotavirus vaccination program in Mexico. Pan Am J Public Health 2009, 25(6):213-222.
8. Valencia-Mendoza A., Bertozzi S.M., Gutierrez J.P., Itzler R. Cost effectiveness of introducing a rotavirus vaccine in developing countries: the case of Mexico. BMC Infectious Diseases 2008, 8:103-115.
9. Consejo Nacional de Población. Proyecciones de población 2000-2050. (In Spanish). México. CONAPO. 2007. Available: (Accessed 21 August 2007). http://www.conapo.mx/.
10. Dirección Técnica de Información Estadística en Salud (DTIES). Instituto Mexicano del Seguro Social (IMSS). (In Spanish). 2005. Personal Communication. Mexico.
11. Secretaría de Salud (SSA). Annual Report of Statistics. 2001-2006a. (In Spanish). Available: (Accessed September 2007). http://sinais.salud.gob.mx/publicaciones/.
12. Secretaría de Salud (SSA). Bulletin of statistical information. México. 2006. (In Spanish). Available: (Accessed September 2007). http://sinais.salud.gob.mx/publicaciones/.
13. O'Ryan M., Perez-Schael I., Mamani N., Pena A., Salinas B., Gonzalez G., et al. Rotavirus associated medical visits and hospitalizations in South America: a prospective study at three large sentinel hospitals. Pediatr Infect Dis J 2001, 20(7):685-693.
14. Secretaria de Salud (SSA). Main causes of death in preschoolers. National system of information in health. México. 2001-2006b. Available: (Accessed 21 August 2007). http://sinais.salud.gob.mx/mortalidad/mortalidad.htm.
15. Murray C.J.L., Lopez A.D. The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries and risk factors in 1990 and projected to 2020 1996, Harvard University Press, Cambridge.
16. Velazquez F.R., Calva J.J., Guerrero M.L., Mass D., Glass R.I., Pickering L.K., et al. Cohort study of rotavirus serotype patterns in symptomatic and asymptomatic infections in Mexican children. Pediatr Inf Dis J 1993, 12:54-61.
17. Liddle J.L., Burgess M.A., Gilbert G.L., Hanson R.M., McIntyre P.B., Bishop R.F., et al. Rotavirus gastroenteritis: impact on young children, their families and the health care system. Med J Aust 1997, 15:304-307.
18. World Health Organization (WHO) (2000). Statistical Information System (WHOSIS). Life tables for Mexico. Available at: (Accessed 31 August 2010). http://apps.who.int/ghodata/%23.
19. Granados V., Velázquez F.R., Garduño-Espinosa J., Torres-López J., Muñoz-Hernandez O. Resource utilization and costs of treating severe rotavirus diarrhea in Mexican young children. Revista de Investigacion Clínica 2009, 61(1):18-25.
20. Arredondo A., Damian T., Icaza E. An approximation to the study of costs of health services in Mexico (In Spanish). Salud Publica Mex 1995, 37(5):437-445.
21. Melliez H., Levybruhlb D., Boelle P.Y., Dervauxd B., Baron S., Yazdanpanaha Y. Cost and cost effectiveness. Vaccine 2008, 26:706-715.
22. Ramani S., Kang G. Burden of disease and molecular epidemiology of a group A rotavirus infections in India. Indian J Medical Res 2007, 125:619-632.
23. Lu Chun-Yi, Lauderdale T.S., Fang Y., Wang, Chung-Yi, Ho Yu-Huai, Hung Che-Lun, Chang Luan-Yin, Lee Chin-Yun, Huang Li-Min. BCM Infectious diseases. 2006, 6:176.
24. Linhares A.C., Gabbay B., Freitas R.B., Travassos E.S., Rosa D.A., Mascarenhas J.D.P., Loureiro E.C.B. Longitudinal study of rotavirus infections among children from Belém. Brazil Epidem Inf 1989, 102:129-145.
25. Velázquez F.R., Matson D.O., Calva J.J., Guerrero L., Morrow A.L., Carter-Campbell S., et al. Rotavirus Infection against subsequent Infections. The New Engl J Med 1996, 335(14):1022-1028.
26. Ehrenkranz P., Lanata C.F., Penny M.E., Salazar-Lindo E., Glass R.I. Rotavirus diarrhea disease burden in Peru: the need for a rotavirus vaccine and its potential cost savings. Am J Public Health 2001, 10:240-248.
27. Naficy A.B., Abu-Elyazeed R., Holmes J.L., Rao M.R., Savarino S.J., Kim Y., et al. Epidemiology of rotavirus diarrhea in Egyptian children and implications for disease control. Am J Epidemiol 1999, 150:770-777.
28. Bilcke J, Van Damme P, Van Ranst M, Hens N, Aerts M, Beutels P. Estimating the incidence of symptomatic rotavirus infections: A systematic review and meta-analysis. PloS ONE 4(6): e6060. doi:10.1371/journal.phone.0006060.
29. Jiraphongsa C., Bresee J.S., Pongsuwanna Y., Kluabwang P., Poonawagul U., Arporntip P., et al. Epidemiology and burden of rotavirus diarrhea in Thailand: results and sentinel surveillance. J Infect Dis 2005, 192(Suppl. (1)):S87-S93.
30. Salinas B., Pérez Schael I., Linhares A.C., Ruiz Palacios G.M., Guerrero M.L., Yarzábal J.P., et al. Evaluation of safety, immunogenicity and efficacy of an attenuated rotavirus vaccine, RIX4414: A randomized, placebo-controlled trial in Latin American infants. Pediatr Infect Dis J 2005, 24(9):807-816.
31. Kosek M., Bern C., Guerrant R.L. The global burden of diarrheal disease as estimated from studies published between 1992 and 2000. Bull World Health Organ 2003, 81:197-204.
32. Sartori A.M.C., Valentim J., de Soárez P.C., Novaes H.M.D. Rotavirus morbidity and mortality in children in Brazil. Rev Panam Salud Pública 2008, 23(2):92-100.
33. Constenla D., Pérez-Schael I., Rheingans R.D., Antil L., Salas H., Yarzábal J.P. Evaluación del impacto económico de la vacuna antirrotavírica en Venezuela. (In Spanish) Rev Panam Salud Publica 2006, 20(4):213-222.
34. Constenla D., O'Ryan M., Navarrete M.S., Antil L., Rheingans R. Evaluacion de costo efectividad de la vacuna antirotavirus en Chile (In Spanish). Rev Med Chile 2006, 134:679-688.
35. Podewils L.J., Antil L., Hummelman E., Bresee J., Parashar U.D., Rheingans R. Projected cost effectiveness of rotavirus vaccination for children in Asia. J Infect Dis 2005, 192(Suppl. (1)):S133-S145.
36. Fischer T.K., Anh D.D., Antil L., Cat N.D., Kilgore P.E., Thiem V.D., et al. Health care costs of diarrheal disease and estimates of the cost-effectiveness of rotavirus vaccination in Vietnam. J Infect Dis 2005, 192(10):1720-1726.
37. Tate J.E., Chitambar S., Esposito D.H., Sarkar R., Gladstone B., Ramani S., et al. Disease and economic burden of rotavirus diarrhoea in India. Vaccine 2009, F18-F24.
38. Yeea E.L., Fang Z.Y., Liu N., Hadler S.C., Liang X., Wang H., et al. Importance and challenges of acurately counting rotavirus deaths in China, 2002. Vaccine 2009, F46-F49.
39. Wilopo S.A., Kilgore P., Kosen S., Soenarto Y., Aminah S., Cahyono A., et al. Economic evaluation of a routine rotavirus vaccination programme in Indonesia. Vaccine 2009, 27:F67-F74.
40. Velazquez F.R., Garcia-Lozano H., Rodriguez E., Cervantes Y., Gomez A., Melo M., et al. Diarrhea morbidity and mortality in Mexican children. Impact of rotavirus. Pediatr Inf Dis J 2004, 23:S149-S155.
41. World Health Organization. The Global burden of disease. 2004 update. Switzerland. 2008. WHO. Available at: (accessed February 2011). http://www.who.int/healthinfo/global_burden_disease/GBD_report_2004update_coverTOC.pdf.